Solid Tumors and Recurrent or progressive primary CNS tumors
Study Name: FORE
- Cancer Stage: III or IV
- Key Inclusion: BRAF alterations
- Description: A Study to Assess the Efficacy and Safety of FORE8394 in Participants with Cancer Harboring BRAF Alterations
- Study Number: F8394-201
- NCT#: NCT05503797
For more information, call 240-566-4100 or email clinicaltrials@frederick.health
-
Frederick, MD 21702
301-694-5861 More Information -
Frederick, MD 21702
301-663-4774 More Information -
Frederick, MD 21702
240-215-6310 More Information -
Frederick, MD 21702
301-694-5580 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4500 More Information
/
View All